Home NDC 71403-049 Sitavig
Product NDC 71403-049
11-digit product format 714030049
Labeler code 71403
Product ID 71403-049_7e36e856-cd1b-481d-bc96-846ac59b1548
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form TABLET, DELAYED RELEASE
Route BUCCAL
Labeler EPI Health, Inc
Application NDA203791
Marketing category NDA
Marketing start 2014-03-20
Marketing end 0000-00-00
Substance ACYCLOVIR
Active strength 50 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 71403-049-02 Sitavig 1 in 1 CARTON TABLET, DELAYED RELEASE 1 5 71403-049-02 Sitavig 2 in 1 BLISTER PACK TABLET, DELAYED RELEASE 2 5
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 71403-049 SITAVIG (ACYCLOVIR) TABLET, DELAYED RELEASE [EPI HEALTH, INC] 5 Legacy NDC, 2 package rows 20200612_cd6e902d-5753-49ec-bec8-b27176ed978e.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 71403-049-02 71403004902 1 BLISTER PACK in 1 CARTON (71403-049-02) > 2 TABLET, DELAYED RELEASE in 1 BLISTER PACK 1 blister pack 2014-03-20 0000-00-00 No No Current